Figure 2. Kaplan–Meier analysis of survival curves among pre-dialysis stage 5 CKD patients.

Dialysis-free (A) and mortality-free (B) survivals constitute the study end points. Difference between dipyridamole users and non-users was analyzed by log-rank test. Abbreviations: CKD, chronic kidney disease.